Foxtrot: Neoadjuvant Folfox Chemotherapy In Colorectal Cancer

FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancer

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancer

FOxTROT Trial Sheds Light on Neoadjuvant Therapy for Colorectal Cancer

Overview of RAPIDO trial in rectal cancer and FOxTROT trial in colon cancer

Neoadjuvant and adjuvant chemotherapy with TME in T3 rectal cancer

FOLFOX with 5FUCRT is non-inferior to 5FUCRT for treatment of LARC

Dion Morton, Philip Quirke – Neoadjuvant chemotherapy for advanced colon cancer

European Colorectal Congress

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

Rectal Cancer Evidence

Updates in adjuvant and neoadjuvant treatment for colon cancer

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. Stintzing

European Society for Medical Oncology (ESMO)

Postoperative Chemotherapy for Advanced Rectal Cancer

The benefits and pitfalls of total neoadjuvant therapy in rectal cancer

Neoadjuvant and Adjuvant Therapy in Metastatic Colorectal Cancer

Elucidating the optimal total neoadjuvant therapy in rectal cancer

Laparoscopy in Colorectal Cancer

Total neoadjuvant therapy + pembrolizumab in locally-advanced rectal cancer

Exploring the Neoadjuvant Treatment of Rectal Cancer

Neoadjuvant/Adjuvant Approaches in Colorectal Cancer

Biomarker testing and targeted therapies in colorectal cancer